Research & Development: Page 93
-
PharmaVoice Team/PharmaVoice
What's New
New Healthcare-related Products, Services, and Companies inChord and DWA Create New Agency The new agency’s focus is on providing pharmaceutical and healthcare marketing to clients in Italy and the surrounding region. inChord Communications Inc. and DWA have partnered to create a new agency, DWA ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
A Candid Visionary - Dr. Candace Kendle
November 2005 PharmaVOICE Photography: Donald Ventre/Ventre Photo Illustration With a mix of inspiration and perspiration, Candace Kendle, Pharm.D., has built a small pharma project management and monitoring service into a large, globally respected clinical research organization. A stalwart, neve...
By Kim Ribbink • Jan. 2, 2008 -
Explore the Trendline➔
Stock via Getty Images
TrendlineClinical trial diversity
As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
PharmaOutlet
Dr. Ronald Salerno Contributed by Dr. Ronald Salerno Advancing the Science Last spring’s Drug Industry Association (DIA) workshop on pharmacogenomics reflected a much more mature, developed environment than previous workshops, paralleling the recent advances in the field. As an industry, we conti...
By Dr. Ronald Salerno • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, Marketing, and R&D Trends from Industry Analysts Pharma Trax November 2005 Consumers Concerned about Unnecessary Medical Treatment A considerable number of U.S. adults are concerned about the frequency with which patients are medically overtreated by their doctors. This is a finding of...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Power of ePRO
In the past few years, drug developers and regulatory agencies have become increasingly receptive to the use of electronic patient-reported outcomes (ePRO) devices in clinical trials. The vast majority of patient-reported outcomes are still recorded in paper-based diaries, but a broad range of ap...
By Autumn Konopka • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Raise Your Voice -- Letters
November 2005 Lessons to be learned As illustrated by the recent issues surrounding the drug Vioxx, there are times when the desire for marketability of treatments may overlook small but potentially grave safety concerns arising from clinical trials. Of all the important lessons to be learned fro...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Paperless Trials: Fact, Fiction, or a Little Bit of Both?
Electronic Data capture Paperless Trials: Fact, Fiction, or a Little Bit of Both? EDC has gone through many iterations in the past couple of years. While the technologies and processes have evolved significantly from the early days, the move to a completely paperless environment is still ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
i3 Creates Drug Safety Business The new business unit is responding to the industry’s need for greater vigilance regarding the safety of drugs. i3 has introduced i3 Drug Safety, a new business unit created to unite all of the organization’s epidemiology and drug-safety resources into one unit to ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
PharmaTrax Cardiovascular Drug Market to Top $100 Billion by 2008 The worldwide market for prescription cardiovascular medications, which topped $75 billion in 2004, will surpass the $100 billion mark by 2008, according to a new report released by Kalorama Information titled The Worldwide M...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
New Electronic and Web-based Applications, Sites, and Technologies E-media PhRMA Website Educates Consumers on the Risks of Importing Drugs Citing a growing body of information that opening the U.S. borders to foreign drugs is risky and unsafe, the Pharmaceutical Research and Manufact...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
Industry Event On the Calendar PharmaVOICE October 2005 October 17-18 3rd Annual Mid-Market Healthcare M&A & Corporate Development Conference Loews Vanderbilt Hotel, Nashville, Tenn. For more information, contact Sandro Pardo, Strategic Research Institute, at 212-967-0095 x234, e-mail spa...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
The spirit of giving Fifth Annual PharmaLinx Charity Golf Outing Linda Beneze from PHT Corp., a gold sponsor of the event, and Taren Grom, editor of PharmaVOICE, take a moment during the Fifth Annual PharmaLinx Charity Golf Outing. The pharmaceutical and life-sciences industries have on...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Avtar Dhillon - Successful Returns
Avtar Dhillon – Successful Returns October 2005 PharmaVOICE A scientist’s perseverance and foresight, a doctor’s compassion, and an entrepreneur’s penchant for turning business opportunities into successful ventures are just some of the traits that define the multifaceted career of Avtar D...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
On the Cover The management of customer relationship management Having lagged behind other industries in terms of capitalizing on customer data, the pharmaceutical arena is catcthing up. The industry is beginning to fully commit to learn more about its customers, and is using that information to ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Raise Your Voice -- Letters
Putting the “Community” in Community Service A call to action Hurricane Katrina damaged or destroyed dozens of research sites along the Gulf Coast and dislocated hundreds of employees and thousands of study participants. Pharmaceutical and biotechnology companies reacted quickly ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
On the Road to Personalized Medicine
On the Road to Personalized Medicine The use of biomarkers in clinical drug development will usher in the age of personalized medicine, allowing developers to predict a patient’s response to a compound. The result will be not only better treatment for patients, ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
5th Annual PharmaLinx Charity Golf Outing
5th Annual PharmaLinx Charity Golf Outing Raising More than $20,000 for the Lankenau Institute for Medical Research Hosted by PharmaVoice Magazine and AXIS Healthcare Communications LLC 1. Dr. Vincent Cristofalo from Lankenau Institute (LIMR) and Lisa Banket from PharmaVOICE share a momen...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
What’s New New healthcare-related products, services, and companies GfK Group Integrates U.S. Healthcare Businesses GfK Group has consolidated its U.S. healthcare activities under GfK U.S. HealthCare Companies. This move follows GfK’s acquisition of NOP World, as well as its full acquisition of G...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
ECG Goes Digital
ECG Goes Digital By Denise Myshko With regulatory agencies placing a greater emphasis on cardiac safety, pharmaceutical companies are now required to test all drugs for their impact on cardiac repolarization. Electronic data capture and transfer technologies are making this a much more manageable...
By Denise Myshko • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
Suite of Technology Solutions Addresses Safety Issues Life-sciences organizations face increasing scrutiny from consumers, healthcare professionals, regulatory agencies, and legislators. As a result, it is critical that they take a proactive approach to the way adverse-event cases are received, p...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Six Sigma: Quality Improvement Programs
Six Sigma: Quality Improvement Programs Implementing a six sigma quality improvement program is not a magic pill to instantly improve business performance. Instead it is a structured way to improve the product or service delivered to customers while improving business efficiency. The Six Sigma qu...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The CRA: A Key to Site Effectiveness
The CRA: A Key to Site Effectiveness Clinical Research Associates By Denise Myshko Electronic data capture and other clinical-research technologies are having a far-reaching impact that extends beyond just the quick and efficient gathering of data. Clinical research associates — employed by the s...
By Denise Myshko • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's on Your Mind -- Opinions
Opinions Six Sigma: A Process Strategy The vision for Six Sigma is not just about bottom-line savings. Within the last few years, Six Sigma programs have become geared toward stimulating top-line growth by focusing on critical aspects of company-centric design processes. PharmaVOICE asked: Does y...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
Table of Contents September 2005 On the Cover Pharmaceutical industry image: Regaining the trust Repairing the pharmaceutical industry’s tarnished image is a major undertaking that many believe has barely begun. All sectors of the industry need to unite behind a single message and purpose: to res...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
In June, PharmaVOICE hosted its first Pharmaceutical Marketers KnowledgeShare Forum, a two-day event that brought together top-level executives from throughout the industry to engage in a meaningful dialogue on a number of subjects impacting the marketing sector. On the second day of this event, ...
By Taren Grom • Jan. 2, 2008
Previous
